Historical outcomes for patients with stage IA NLPHL: RGlobal nLPHL One Working Group (GLOW) retrospective analyses.
Flerlage JE, Eichenauer DA, Fuchs M, Hartmann S, Eich HT, Savage KJ, Lo AC, Skinnider B, Akhtar S, Rauf MS, Maghfoor I, Pinnix CC, Steiner RE, Milgrom SA, Vega F, Alomari M, Zhang XY, Collins GP, Advani RH, Kumar P, Dickinson MJ, Wirth A, Tsang R, Prica A, Major A, Smith SM, Hendrickson PG, Kelsey CR, Hopkins D, McKay P, Ng AK, Koenig JL, Constine LS, Casulo C, Sakthivel G, Baron JA, Plastaras JP, Roberts KB, Gao S, Al Kendi J, Al Rahbi N, Balogh AG Jr, Levis M, Ricardi U, Sridhar A, Torka P, Specht L, De Silva R, Shah N, Pickard K, Osborne W, Blazin LJ, Henry M, Chang I, Smith CM, Halperin D, Miall F, Brady JL, Mikhaeel NG, Brennan B, Penn A, Senchenko M, Volchkov EV, Reeves M, Hoppe BS, Terezakis SA, Talaulikar D, Della Pepa R, Picardi M, Kirova Y, Fergusson P, Northend M, Hawkes EA, Lee D, Wong Doo N, Barraclough A, Opat S, Cheah CY, Salvaris R, Ku M, Hamad N, Mutsando H, Tedjaseputra A, Gilbertson M, Marconi T, Viiala N, Palese M, Shankar AG, Maurer MJ, Natkunam Y, Kelly KM, Borchmann P, Hoppe RT, Binkley MS.
Flerlage JE, et al.
Blood Adv. 2026 Apr 14:bloodadvances.2026020012. doi: 10.1182/bloodadvances.2026020012. Online ahead of print.
Blood Adv. 2026.
PMID: 41979337